These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26370014)

  • 41. Cost-effectiveness of primary and secondary prevention in cardiovascular diseases.
    Troche CJ; Tacke J; Hinzpeter B; Danner M; Lauterbach KW
    Eur Heart J; 1998 Apr; 19 Suppl C():C59-65. PubMed ID: 9597427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary prevention for cardiovascular diseases: can statins replace aspirin?
    Abdul Hadi M; Ming LC; Awaisu A
    Med Princ Pract; 2011; 20(6):584. PubMed ID: 21986022
    [No Abstract]   [Full Text] [Related]  

  • 43. [Primary prevention of cardiovascular diseases with statins in patients with diabetes].
    Macías Saint-Gerons D; de la Fuente Honrubia C; de Andrés-Trelles F; Catalá-López F
    Med Clin (Barc); 2015 Mar; 144(6):285-7. PubMed ID: 24954712
    [No Abstract]   [Full Text] [Related]  

  • 44. Statins, risk assessment, and the new American prevention guidelines.
    Lloyd-Jones DM; Goff D; Stone NJ
    Lancet; 2014 Feb; 383(9917):600-2. PubMed ID: 24315619
    [No Abstract]   [Full Text] [Related]  

  • 45. Statins for cardiovascular prevention according to different strategies: a cost analysis.
    Ito MK; Nanchen D; Rodondi N; Paccaud F; Waeber G; Vollenweider P; Marques-Vidal P
    Am J Cardiovasc Drugs; 2011; 11(1):33-44. PubMed ID: 21265581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benefit/risk ratio of statins in primary prevention.
    Reidenberg MM
    Clin Pharmacol Ther; 2008 Mar; 83(3):498-500. PubMed ID: 17538549
    [No Abstract]   [Full Text] [Related]  

  • 47. Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention.
    Yeboah J
    Evid Based Med; 2015 Dec; 20(6):230. PubMed ID: 26337629
    [No Abstract]   [Full Text] [Related]  

  • 48. Statins for the primary prevention of cardiovascular disease in women?
    Birge SJ
    Menopause; 2012 Dec; 19(12):1287-8. PubMed ID: 23187611
    [No Abstract]   [Full Text] [Related]  

  • 49. Starting statins for primary prevention of cardiovascular disease.
    Tunstall-Pedoe H
    Heart; 2013 Nov; 99(21):1547-8. PubMed ID: 23878178
    [No Abstract]   [Full Text] [Related]  

  • 50. Statins: new American guidelines for prevention of cardiovascular disease.
    Ridker PM; Cook NR
    Lancet; 2013 Nov; 382(9907):1762-5. PubMed ID: 24268611
    [No Abstract]   [Full Text] [Related]  

  • 51. The public cost of 3 statins for primary prevention of cardiovascular events in 7 Middle East countries: not all of them can afford it.
    Isma'eel H; Mohanna Z; Hamadeh G; Alam E; Badr K; Alam S; Rebeiz A
    Int J Cardiol; 2012 Mar; 155(2):316-8. PubMed ID: 22217486
    [No Abstract]   [Full Text] [Related]  

  • 52. Statins for primary prevention.
    Tejani AM; Musini V; Bassett K; Dormuth C; Perry T; Wright JM
    CMAJ; 2012 Apr; 184(7):791; author reply 791-2. PubMed ID: 22508992
    [No Abstract]   [Full Text] [Related]  

  • 53. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statins for primary prevention of cardiovascular disease : Patients need better tools to navigate divergent recommendations.
    Otto CM
    Heart; 2017 Apr; 103(7):477-478. PubMed ID: 27940966
    [No Abstract]   [Full Text] [Related]  

  • 55. [Primary prevention of cardiovascular diseases with statins in women].
    Alici G; Karpuz V; Karpuz H
    Turk Kardiyol Dern Ars; 2009 Jun; 37(4):273-80. PubMed ID: 19717964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statins for everyone--(even for those at low risk.) Experts are excited, but the question is whether benefits would outweigh costs.
    Duke Med Health News; 2009 Feb; 15(2):1, 11. PubMed ID: 19358321
    [No Abstract]   [Full Text] [Related]  

  • 57. Benefits and Harms of Using Statins to Prevent Cardiovascular Disease.
    Ann Intern Med; 2019 Jan; 170(1):. PubMed ID: 30508420
    [No Abstract]   [Full Text] [Related]  

  • 58. Cardiovascular primary prevention: how high should we set the bar?
    Prasad V; Vandross A
    Arch Intern Med; 2012 Apr; 172(8):656-9; discussion 659. PubMed ID: 22529231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary Prevention Statins in Older Patients: The Good News or the Bad News First?
    Kirkpatrick JN; Bernacki GM
    J Am Coll Cardiol; 2020 Jul; 76(1):28-30. PubMed ID: 32616159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of Statins in Adults Older Than 75 Years.
    Stone NJ; Blum CB
    JAMA; 2017 Mar; 317(10):1081. PubMed ID: 28291887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.